Stay updated on SRX246 in Huntington's Disease: Tolerability Clinical Trial
Sign up to get notified when there's something new on the SRX246 in Huntington's Disease: Tolerability Clinical Trial page.

Latest updates to the SRX246 in Huntington's Disease: Tolerability Clinical Trial page
- CheckyesterdayChange DetectedNo significant changes to core study information (purpose, design, eligibility criteria, or locations) were observed; the differences appear to be non-substantive metadata updates such as timestamps or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check29 days agoChange DetectedCore content updated with a new operating-status notice and v3.2.0; a specific resource entry (Huntington disease) was removed, and v3.1.0 was deleted.SummaryDifference4%

- Check37 days agoChange DetectedCore content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.SummaryDifference0.4%

- Check51 days agoChange DetectedRevision updated to v3.0.2 (from v3.0.1); the 'Back to Top' link was removed.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific references to Huntington's disease and drug safety, while removing several location-related terms and specific drug categories.SummaryDifference3%

Stay in the know with updates to SRX246 in Huntington's Disease: Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SRX246 in Huntington's Disease: Tolerability Clinical Trial page.